These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8372950)

  • 1. Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells with mitotic figure content and tumor grade.
    Weidner N; Moore DH; Ljung BM; Waldman FM; Goodson WH; Mayall B; Chew K; Smith HS
    Am J Surg Pathol; 1993 Oct; 17(10):987-94. PubMed ID: 8372950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
    Weidner N; Moore DH; Vartanian R
    Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
    Thor AD; Liu S; Moore DH; Edgerton SM
    J Clin Oncol; 1999 Feb; 17(2):470-7. PubMed ID: 10080587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.
    Meyer JS; Alvarez C; Milikowski C; Olson N; Russo I; Russo J; Glass A; Zehnbauer BA; Lister K; Parwaresch R;
    Mod Pathol; 2005 Aug; 18(8):1067-78. PubMed ID: 15920556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
    Lehr HA; Hansen DA; Kussick S; Li M; Hwang H; Krummenauer F; Trouet S; Gown AM
    Hum Pathol; 1999 Nov; 30(11):1314-20. PubMed ID: 10571511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma.
    Meyer JS; Koehm SL; Hughes JM; Higa E; Wittliff JL; Lagos JA; Manes JL
    Cancer; 1993 Jun; 71(11):3531-40. PubMed ID: 8490901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
    Keshgegian AA; Cnaan A
    Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
    Vartanian RK; Weidner N
    Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit.
    Lloveras B; Edgerton S; Thor AD
    Am J Clin Pathol; 1991 Jan; 95(1):41-7. PubMed ID: 1987751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer.
    Goodson WH; Moore DH; Ljung BM; Chew K; Florendo C; Mayall B; Smith HS; Waldman FM
    Breast Cancer Res Treat; 1998 May; 49(2):155-64. PubMed ID: 9696398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
    Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS
    Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling.
    Meyer JS; Nauert J; Koehm S; Hughes J
    J Histochem Cytochem; 1989 Sep; 37(9):1449-54. PubMed ID: 2768814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of standardized mitotic indices to other prognostic factors in breast cancer.
    Gaffney EV; Venz-Williamson TL; Hutchinson G; Biggs PJ; Nelson KM
    Arch Pathol Lab Med; 1996 May; 120(5):473-7. PubMed ID: 8639051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor.
    Clayton F
    Cancer; 1991 Sep; 68(6):1309-17. PubMed ID: 1651805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation in hyperplastic and in situ carcinoma lesions of the breast estimated by in vivo labeling with bromodeoxyuridine.
    Christov K; Chew KL; Ljung BM; Waldman FM; Goodson WH; Smith HS; Mayall BH
    J Cell Biochem Suppl; 1994; 19():165-72. PubMed ID: 7823588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.
    Limas C; Bigler A; Bair R; Bernhart P; Reddy P
    J Clin Pathol; 1993 Feb; 46(2):159-65. PubMed ID: 8459037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences on measurement of cellular proliferation by histology and flow cytometry in mammary carcinomas labeled in vivo with bromodeoxyuridine.
    Going JJ; Stanton PD; Cooke TG
    Am J Clin Pathol; 1993 Sep; 100(3):218-22. PubMed ID: 8379529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.